Transcription of Procedure for Subcutaneous Insertion, Removal, …
{{id}} {{{paragraph}}}
PALLIATIVE CARE PROGRAM. Procedure for Subcutaneous insertion , removal , and Medication Administration Review: April 2017. APPROVED: [June 2015]. WRHA Palliative Care Program Programme de soins palliatifs, ORSW. Procedure for Subcutaneous insertion , removal and Medication Administration PART I: Establishing a Subcutaneous Site PART II: Intermittent Subcutaneous Medication Administration PART III: removal of a Subcutaneous Device PART IV: Special Note Regarding Pediatric Patients and Insuflon Catheters APPENDIX A: Subcutaneous Medication Compatibility APPENDIX B: Subcutaneous insertion Sites PURPOSE: To provide an evidence-based, standard approach to establishing a Subcutaneous route for medication in non-emergent situations in the home (when other routes of administration are contraindicated or unavailable.)
The subcutaneous site must be changed every seven (7) days or sooner, if necessary. When changing sites, the chosen sites should be …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
ADULT INSULIN PRESCRIPTION AND BLOOD, SUBCUTANEOUS INSULIN, Insulin, Patients, Insulin infusion, Patients requiring, Variable rate intravenous insulin infusion, Variable rate intravenous insulin infusion VRIII, SURGERY ALGORITHM FOR PATIENTS WITH, Bydureon Bcise PI, BYDUREON BCISE, Joslin Clinical Guideline for Inpatient, Inpatient Management of Hyperglycemia and